Login / Signup

High biochemical recurrence rate after withdrawal of cabergoline in prolactinomas: is it necessary to restart treatment?

Etual Espinosa-CárdenasMiriam Sánchez-GarcíaClaudia Ramírez-RenteríaVictoria Mendoza-ZubietaErnesto Sosa-ErozaMoises Mercado
Published in: Endocrine (2020)
Biochemical recurrence in prolactinomas is very frequent, however, in only a few of these patients reinitiation of DA is necessary.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • patient reported outcomes